Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model
Preclinical
Abstract
A Rhodiola rosea root and rhizome ethanolic extract counteracted the neuroinflammatory effect of corticotropin-releasing hormone in BV2 microglial cells by inhibiting NF-kappaB nuclear translocation and modulating MAPK signalling, reducing HSP70 expression and supporting its anti-stress, anti-inflammatory action.
Referenced for these plants
How to cite
Borgonetti, V., Governa, P., Biagi, M., Dalia, P. and Corsi, L (2019) 'Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model', Phytomedicine, 68, pp. 153143. doi:10.1016/j.phymed.2019.153143
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.